01:06 to 03:08
Rea F, Biffi A, Ronco R, Franchi M, Cammarota S, Citarella A, Conti V, Filippelli A, Sellitto C, Corrao G. Cardiovascular Outcomes and Mortality Associated With Discontinuing Statins in Older Patients Receiving Polypharmacy. JAMA Netw Open. 2021 Jun 1;4(6):e2113186. doi: 10.1001/jamanetworkopen.2021.13186. PMID: 34125221; PMCID: PMC8204202.
03:10 to 05:11
Hess CN, Cannon CP, Beckman JA, Goodney PP, Patel MR, Hiatt WR, Mues KE, Orroth KK, Shannon E, Bonaca MP. Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease. J Am Coll Cardiol. 2021 Jun 22;77(24):3016-3027. doi: 10.1016/j.jacc.2021.04.060. PMID: 34140105.
05:32 to 07:23
Ren QW, Yu SY, Teng TK, Li X, Cheung KS, Wu MZ, Li HL, Wong PF, Tse HF, Lam CSP, Yiu KH. Statin associated lower cancer risk and related mortality in patients with heart failure. Eur Heart J. 2021 Jun 22:ehab325. doi: 10.1093/eurheartj/ehab325. Epub ahead of print. PMID: 34157723.
07:24 to 09:08
Qie R, Liu L, Zhang D, Han M, Wang B, Zhao Y, Liu D, Guo C, Li Q, Zhou Q, Tian G, Huang S, Wu X, Qin P, Li J, Cao J, Zhang M, Huang J, Lu J, Hu D. Dose-Response Association Between High-Density Lipoprotein Cholesterol and Stroke: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Prev Chronic Dis. 2021 May 13;18:E45. doi: 10.5888/pcd18.200278. PMID: 33988499; PMCID: PMC8139481.

Cardiowatch - fourth episode

01:12 to 03:13
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. N Engl J Med. 2021 Jun 28. doi: 10.1056/NEJMoa2108269. Epub ahead of print. PMID: 34215025.
03:15 to 05:18
Ye N, Jardine MJ, Oshima M, Hockham C, Heerspink HJL, Agarwal R, Bakris G, Schutte AE, Arnott C, Chang TI, Górriz JL, Cannon CP, Charytan DM, de Zeeuw D, Levin A, Mahaffey KW, Neal B, Pollock C, Wheeler DC, Luca Di Tanna G, Cheng H, Perkovic V, Neuen BL. Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights from the CREDENCE Trial. Circulation. 2021 May 4;143(18):1735-1749. doi: 10.1161/CIRCULATIONAHA.120.048740. Epub 2021 Feb 8. PMID: 33554616.
05:52 to 07:12
Zhou JJ, Koska J, Bahn G, Reaven P. Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT. J Clin Endocrinol Metab. 2021 Mar 25;106(4):1150-1162. doi: 10.1210/clinem/dgaa941. PMID: 33367811; PMCID: PMC7993576.

07:13 to 08:57
Shen L, Kristensen SL, Bengtsson O, Böhm M, de Boer RA, Docherty KF, Inzucchi SE, Katova T, Køber L, Kosiborod MN, Langkilde AM, Lindholm D, Martinez MFA, O'Meara E, Nicolau JC, Petrie MC, Ponikowski P, Sabatine MS, Schou M, Sjöstrand M, Solomon SD, Jhund PS, McMurray JJV. Dapagliflozin in HFrEF Patients Treated with Mineralocorticoid Receptor Antagonists: An Analysis of DAPA-HF. JACC Heart Fail. 2021 Apr;9(4):254-264. doi: 10.1016/j.jchf.2020.11.009. Epub 2021 Feb 3. PMID: 33549554.

CardioWatch Episode 5

01:45 to 03:57
Atwater BD, Li Z, Pritchard J, Greiner MA, Nabutovsky Y, Hammill BG. Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation. Circ Cardiovasc Qual Outcomes. 2021 Aug;14(8):e007580. doi: 10.1161/CIRCOUTCOMES.120.007580. Epub 2021 Jul 21. PMID: 34284598.
 
03:58 to 05:25
Liu X, Li W, Wang L, Tian S, Zhou X, Wu M. Safety and efficacy of left bundle branch pacing in comparison with conventional right ventricular pacing: A systematic review and meta-analysis. Medicine (Baltimore). 2021 Jul 9;100(27):e26560. doi: 10.1097/MD.0000000000026560. PMID: 34232199; PMCID: PMC8270617.
 
06:00 to 07:52
Gasperetti A, Schiavone M, Ziacchi M, Vogler J, Breitenstein A, Laredo M, Palmisano P, Ricciardi D, Mitacchione G, Compagnucci P, Bisignani A, Angeletti A, Casella M, Picarelli F, Fink T, Kaiser L, Hakmi S, Calò L, Pignalberi C, Santini L, Lavalle C, Pisanò E, Olivotto I, Tondo C, Curnis A, Dello Russo A, Badenco N, Steffel J, Love CJ, Tilz R, Forleo G, Biffi M. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience. Heart Rhythm. 2021 Jul 14:S1547-5271(21)01866-X. doi: 10.1016/j.hrthm.2021.07.008. Epub ahead of print. PMID: 34271173.

Cardiowatch - Sixth - Episode

01:06 to 02:33
Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Piña IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Preserved Trial Investigators. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMoa2107038. Epub ahead of print. PMID: 34449189.

02:35 to 04:10
Valgimigli M, Frigoli E, Heg D, Tijssen J, Jüni P, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Tonino PAL, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stanković G, Iñiguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Moschovitis A, Laanmets P, Donahue M, Leonardi S, Smits PC; MASTER DAPT Investigators. Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. N Engl J Med. 2021 Aug 28. doi: 10.1056/NEJMoa2108749. Epub ahead of print. PMID: 34449185.

04:15 to 05:43
Frøbert O, Götberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, Oldroyd KG, Motovska Z, Erglis A, Moer R, Hlinomaz O, Jakobsen L, Engstrøm T, Jensen LO, Fallesen CO, Jensen SE, Angerås O, Calais F, Kåregren A, Lauermann J, Mokhtari A, Nilsson J, Persson J, Stalby P, Islam AKMM, Rahman A, Malik F, Choudhury S, Collier T, Pocock SJ, Pernow J. Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Circulation. 2021 Aug 30. doi: 10.1161/CIRCULATIONAHA.121.057042. Epub ahead of print. PMID: 34459211.

 
06:17 to 07:40
Desch S, Freund A, Akin I, Behnes M, Preusch MR, Zelniker TA, Skurk C, Landmesser U, Graf T, Eitel I, Fuernau G, Haake H, Nordbeck P, Hammer F, Felix SB, Hassager C, Engstrøm T, Fichtlscherer S, Ledwoch J, Lenk K, Joner M, Steiner S, Liebetrau C, Voigt I, Zeymer U, Brand M, Schmitz R, Horstkotte J, Jacobshagen C, Pöss J, Abdel-Wahab M, Lurz P, Jobs A, de Waha-Thiele S, Olbrich D, Sandig F, König IR, Brett S, Vens M, Klinge K, Thiele H; TOMAHAWK Investigators. Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation. N Engl J Med. 2021 Aug 29. doi: 10.1056/NEJMoa2101909. Epub ahead of print. PMID: 34459570.


07:43 to 08:52
Neal B, Tian M, Li N, Elliott P, Yan LL, Labarthe DR, Huang L, Yin X, Hao Z, Stepien S, Shi J, Feng X, Zhang J, Zhang Y, Zhang R, Wu Y. Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)-A large-scale cluster randomized controlled trial. Am Heart J. 2017 Jun;188:109-117. doi: 10.1016/j.ahj.2017.02.033. Epub 2017 Mar 14. PMID: 28577665.

Cardiowatch - Seventh Episode

01:12 to 02:56
CT or Invasive Coronary Angiography in Stable Chest Pain
DISCHARGE Trial Group, Maurovich-Horvat P, Bosserdt M, Kofoed KF, et.al N Engl J Med. 2022 Mar 4. doi: 10.1056/NEJMoa2200963. Epub ahead of print. PMID: 35240010.
03:01 to 04:58
24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk
Ma Y, He FJ, Sun Q, et. al. N Engl J Med. 2022 Jan 20;386(3):252-263. doi: 10.1056/NEJMoa2109794. Epub 2021 Nov 13. PMID: 34767706.
05:46 to 07:52
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery
Fearon WF, Zimmermann FM, De Bruyne B, et. al. N Engl J Med. 2022 Jan 13;386(2):128-137. doi: 10.1056/NEJMoa2112299. Epub 2021 Nov 4. PMID: 34735046.
07:54 to 10:06
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial
Watanabe H, Morimoto T, Natsuaki M, et. al. JAMA Cardiol. 2022 Mar 2:e215244. doi: 10.1001/jamacardio.2021.5244. Epub ahead of print. PMID: 35234821; PMCID: PMC8892373.

CardioWatch S02E01

01:17 to 03:12
Kandzari DE, et. al.; SPYRAL HTN-ON MED Trial Investigators. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018 Jun 9;391(10137):2346-2355. doi: 10.1016/S0140-6736(18)30951-6. Epub 2018 May 23. PMID: 29803589.

03:13 to 06:07
Räber L, et. al.; PACMAN-AMI collaborators. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial. JAMA. 2022 Apr 3:e225218. doi: 10.1001/jama.2022.5218. Epub ahead of print. PMID: 35368058; PMCID: PMC8978048.

06:48 to 08:58
Mehta SR et. al. COMPLETE Trial Steering Committee and Investigators. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med. 2019 Oct 10;381(15):1411-1421. doi: 10.1056/NEJMoa1907775. Epub 2019 Sep 1. PMID: 31475795.

09:01 to 11:09
A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy (VALOR-HCM) https://clinicaltrials.gov/ct2/show/NCT04349072

CardioWatch S02E02

01:04 to 03:06
Kosiborod MN, et al. Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospitalized for Acute Heart Failure - Results From the EMPULSE Trial. Circulation. 2022 Apr 4. doi: 10.1161/CIRCULATIONAHA.122.059725. Epub ahead of print. PMID: 35377706.
03:08 to 05:06
Ezekowitz JA, et. al. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. Lancet. 2022 Apr 9;399(10333):1391-1400. doi: 10.1016/S0140-6736(22)00369-5. Epub 2022 Apr 2. PMID: 35381194.
05:58 to 08:48
Tita AT, et. al. Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022 May 12;386(19):1781-1792. doi: 10.1056/NEJMoa2201295. Epub 2022 Apr 2. PMID: 35363951.
08:53 to 10:39
Jansen TPJ, et. al. Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial. JACC Cardiovasc Imaging. 2022 Apr 2:S1936-878X(22)00177-2. doi: 10.1016/j.jcmg.2022.03.012. Epub ahead of print. PMID: 35466050.

CardioWatch S02E03

01:18 to 03:42
da Silva RL, et. al. Randomized Clinical Trial on Prevention of Radial Occlusion After Transradial Access Using Nitroglycerin: PATENS Trial. JACC Cardiovasc Interv. 2022 May 23;15(10):1009-1018. doi: 10.1016/j.jcin.2022.02.026. Epub 2022 Mar 21. PMID: 35331684.

03:44 to 06:14
Kodali S, et. al. Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation. J Am Coll Cardiol. 2021 Feb 2;77(4):345-356. doi: 10.1016/j.jacc.2020.11.047. PMID: 33509390.

07:40 to 09:32
Piccini JP,et. al. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. PMID: 35385695.

09:34 to 11:44
Della Bella P et. al. Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial. Circulation. 2022 Jun 21;145(25):1829-1838. doi: 10.1161/CIRCULATIONAHA.122.059598. Epub 2022 Apr 3. PMID: 35369700.

CardioWatch S02E04

01:24 to 03:29
Farber A, et al.; BEST-CLI Investigators. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N Engl J Med. 2022 Dec 22;387(25):2305-2316. doi: 10.1056/NEJMoa2207899. Epub 2022 Nov 7. PMID: 36342173.

03:31 to 05:58
Laffin LJ, et al. Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers. J Am Coll Cardiol. 2023 Jan 3;81(1):1-12. doi: 10.1016/j.jacc.2022.10.013. Epub 2022 Nov 6. PMID: 36351465.

06:02 to 07:49
The EMPA-KIDNEY Collaborative Group; Herrington WG, et al. Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. PMID: 36331190; PMCID: PMC7614055.

07:51 to 09:39
Ishani A, et al.; Diuretic Comparison Project Writing Group. Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. N Engl J Med. 2022 Dec 29;387(26):2401-2410. doi: 10.1056/NEJMoa2212270. Epub 2022 Dec 14. PMID: 36516076.

User 432292486